Literature DB >> 3860259

Purification and kinetic characterization of a dopamine-sulfating form of phenol sulfotransferase from human brain.

R M Whittemore, L B Pearce, J A Roth.   

Abstract

The kinetic and biochemical properties of a purified, monoamine-sulfating form of phenol sulfotransferase (M-PST) from human brain are described. M-PST activity was separated and purified from phenol-sulfating activity by anion-exchange chromatography on DEAE-cellulose and subsequently purified on AffiGel Blue and Sephacryl S-200, routinely giving a final purification of over 20 000-fold, with approximately a 3% yield. The molecular weight of the active species, as estimated by gel filtration chromatography, was 250 000. The purified enzyme was inhibited by NaCl (50% at 325 mM) and showed an optimum for dopamine sulfation at pH 7.0. Of the monoamine substrates examined, 4-methoxytyramine was the most extensively sulfated at 20 microM, while at higher substrate concentrations (200 microM), tyramine was the apparent preferred substrate. Kinetic analysis demonstrated that sulfation by M-PST proceeds via an ordered, bisubstrate reaction mechanism, where 3'-phosphoadenosine 5'-phosphosulfate (PAPS) is the leading substrate. True Km values for dopamine and PAPS were 2.9 and 0.35 microM, respectively. The product inhibitor 3'-phosphoadenosine 5'-phosphate possessed a Ki of 0.07 microM, while the dead-end inhibitor ATP exhibited a Ki of 170 microM.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3860259     DOI: 10.1021/bi00331a013

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

1.  High accuracy in silico sulfotransferase models.

Authors:  Ian Cook; Ting Wang; Charles N Falany; Thomas S Leyh
Journal:  J Biol Chem       Date:  2013-10-15       Impact factor: 5.157

2.  Characterization of bovine tracheobronchial phenol sulphotransferase cDNA and detection of mRNA regulation by cortisol.

Authors:  S J Schauss; T Henry; R Palmatier; L Halvorson; R Dannenbring; J D Beckmann
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

3.  Catalytic mechanism of Golgi-resident human tyrosylprotein sulfotransferase-2: a mass spectrometry approach.

Authors:  Lieza M Danan; Zhihao Yu; Peter J Ludden; Weitao Jia; Kevin L Moore; Julie A Leary
Journal:  J Am Soc Mass Spectrom       Date:  2010-04-02       Impact factor: 3.109

4.  Molecular cloning and expression of novel sulphotransferase-like cDNAs from human and rat brain.

Authors:  C N Falany; X Xie; J Wang; J Ferrer; J L Falany
Journal:  Biochem J       Date:  2000-03-15       Impact factor: 3.857

5.  Platelet abnormalities in aggressive subjects with mental deficiency.

Authors:  D Marazziti; L Palego; S Silvestri; S Presta; C Balestri; A Batistini; L Conti
Journal:  J Psychiatry Neurosci       Date:  1996-03       Impact factor: 6.186

6.  Isotope exchange at equilibrium indicates a steady state ordered kinetic mechanism for human sulfotransferase.

Authors:  Eduard Tyapochkin; Paul F Cook; Guangping Chen
Journal:  Biochemistry       Date:  2008-10-18       Impact factor: 3.162

7.  Functional characterization of two human sulphotransferase cDNAs that encode monoamine- and phenol-sulphating forms of phenol sulphotransferase: substrate kinetics, thermal-stability and inhibitor-sensitivity studies.

Authors:  M E Veronese; W Burgess; X Zhu; M E McManus
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

8.  Paradigms of sulfotransferase catalysis: the mechanism of SULT2A1.

Authors:  Ting Wang; Ian Cook; Charles N Falany; Thomas S Leyh
Journal:  J Biol Chem       Date:  2014-07-23       Impact factor: 5.157

9.  The allosteric binding sites of sulfotransferase 1A1.

Authors:  Ian Cook; Ting Wang; Charles N Falany; Thomas S Leyh
Journal:  Drug Metab Dispos       Date:  2014-12-22       Impact factor: 3.922

10.  Dopamine is a low-affinity and high-specificity substrate for the human UDP-glucuronosyltransferase 1A10.

Authors:  Katriina Itäaho; Michael H Court; Päivi Uutela; Risto Kostiainen; Anna Radominska-Pandya; Moshe Finel
Journal:  Drug Metab Dispos       Date:  2008-12-30       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.